Thursday, March 13, 2025 10:04:02 PM
"Management remains committed to ensuring that SOHM achieves higher revenue growth in 2024 compared to previous years. This includes the revenues from our new ABBIE kits. Dr. David Aguilar, COO added."
"Dr. David Aguilar, COO, shared that the company has received pre-launch and pre-orders for our ABBIE technology kits. This is significant miles stone for the company and we are very happy to transition from Research and Development to commercialization of GLP ABBIE Technology Kits.
The current CRISPR/Cas9 kits business is expected to grow $ 17.4 billion by year 2032."
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-has-Received-ABBIE-Technology-Kits-Pre-Launch-Pre-Orders?id=453974
____
Committed to revenue growth in 2024 with ABBIE Kits?
Milestone?
From R&D to Commercialization?
All seems very empty now...
"Dr. David Aguilar, COO, shared that the company has received pre-launch and pre-orders for our ABBIE technology kits. This is significant miles stone for the company and we are very happy to transition from Research and Development to commercialization of GLP ABBIE Technology Kits.
The current CRISPR/Cas9 kits business is expected to grow $ 17.4 billion by year 2032."
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-has-Received-ABBIE-Technology-Kits-Pre-Launch-Pre-Orders?id=453974
____
Committed to revenue growth in 2024 with ABBIE Kits?
Milestone?
From R&D to Commercialization?
All seems very empty now...
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
